SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 80.14 |
| Enterprise Value ($M) | -35.84 |
| Book Value ($M) | 89.86 |
| Book Value / Share | 0.91 |
| Price / Book | 0.89 |
| NCAV ($M) | 75.64 |
| NCAV / Share | 0.76 |
| Price / NCAV | 1.06 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.85 |
| Return on Assets (ROA) | -0.50 |
| Return on Equity (ROE) | -0.98 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.50 |
| Current Ratio | 3.50 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 147.12 |
| Assets | 161.34 |
| Liabilities | 71.48 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 20.13 |
| Operating Income | -84.93 |
| Net Income | -81.58 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -57.52 |
| Cash from Investing | -4.16 |
| Cash from Financing | 65.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 9.99 | 134.47 | |
| 13G/A | Redmile Group, LLC | 1.10 | -80.52 | |
| 13G/A | EcoR1 Capital, LLC | 4.80 | -7.61 | |
| 13G/A | Gilead Sciences Inc | 19.40 | 398.99 | |
| 13G/A | Fmr Llc | 4.12 | -31.40 | |
| 13G | Knoll Capital Management, LLC | 6.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 128,514 | 477,177 | 26.93 | |
| 181,420 | 23,060 | 786.73 | |
| 198,402 | 116,658 | 170.07 | |
| 273,913 | 114,458 | 239.31 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GTBP – GT Biopharma, Inc. | GYRE – Gyre Therapeutics, Inc. |
| HEPA – Hepion Pharmaceuticals, Inc. | HOTH – Hoth Therapeutics, Inc. |
| HRTX – Heron Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io